INS and diabetes mellitus: The ability of Zn compounds to improve glucose transport, glycogen synthesis and lipogenesis, to inhibit gluconeogenesis and lipolysis, and to modulate key elements of the insulin signalling pathway [17,18] has been suggested to contribute to the improvement of hyperglycemia and glucose homeostasis in diabetes.